A Controlled Study of Olanzapine in Children With Autism

Clinical trial NCT00057408 · COMPLETED

Trial details

NCT number: NCT00057408
Sponsor: FDA Office of Orphan Products Development
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Autistic Disorder

Start date: 2003-05-01
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.